This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Decreased risk of recurrent acute pancreatitis with semaglutide and tirzepatide in people with type 2 diabetes or obesity with a history of acute pancreatitis: A propensity matched global federated TriNetX database-based retrospective cohort study.
Diabetes & metabolic syndrome, 18(9), 103116
Citation
Nassar, Mahmoud; Nassar, Omar; Abosheaishaa, Hazem; Misra, Anoop. (2024). Decreased risk of recurrent acute pancreatitis with semaglutide and tirzepatide in people with type 2 diabetes or obesity with a history of acute pancreatitis: A propensity matched global federated TriNetX database-based retrospective cohort study.. Diabetes & metabolic syndrome, 18(9), 103116. https://doi.org/10.1016/j.dsx.2024.103116